Pulmonary cyclooxygenase-1 (COX-1) and COX-2 cellular expression and distribution after respiratory syncytial virus and parainfluenza virus infection

Viral Immunology

Volumn 23, Issue 1, 2010, Pages 43-48

  Radi, Zaher A ^a   Meyerholz, David K ^b   Ackermann, Mark R ^c  

^a PFIZER INC   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c IOWA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2;

ANIMAL EXPERIMENT; ARTICLE; BRONCHIOLE; BRONCHUS; CONTROLLED STUDY; ENDOTHELIUM CELL; LAMB; LUNG; MACROPHAGE; NONHUMAN; PARAINFLUENZA VIRUS 3; PARAINFLUENZA VIRUS INFECTION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RESPIRATORY EPITHELIUM; SMOOTH MUSCLE FIBER; VIRUS INFECTION;

ANIMALS; ANIMALS, NEWBORN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; LUNG; MACROPHAGES, ALVEOLAR; PARAINFLUENZA VIRUS 3, BOVINE; PARAMYXOVIRIDAE INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; SHEEP;

HUMAN PARAINFLUENZA VIRUS 3; PARAINFLUENZA VIRUS; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EID: 76449115678     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2009.0042     Document Type: Article

References (46)

1. Adawi A, Zhang Y, Baggs R, Finkelstein J, and Phipps RP: Disruption of the CD40-CD40 ligand system prevents an oxygen-induced respiratory distress syndrome. Am J Pathol 1998;152:651-657.
2. Arias-Diaz J, Vara E, Garcia C, and Balibrea JL: Tumor necrosis factor-alpha-induced inhibition of phosphatidylcholine synthesis by human type II pneumocytes is partially mediated by prostaglandins. J Clin Invest 1994;94:244-250.
3. Asano K, Lilly CM, and Drazen JM: Prostaglandin G=H synthase-2 is the constitutive and dominant isoform in cultured human lung epithelial cells. Am J Physiol 1996;271: L126-L131. (Pubitemid 27369268)
4. Bartz H, Buning-Pfaue F, Turkel O, and Schauer U: Respiratory syncytial virus induces prostaglandin E2, IL-10 and IL-11 generation in antigen presenting cells. Clin Exp Immunol 2002;129:438-445.
5. Bennett BL, Garofalo RP, Cron SG, Hosakote YM, Atmar RL, MaciasCG, andPiedraPA: Immunopathogenesis of respiratory syncytial virus bronchiolitis. J Infect Dis 2007;195:1532-1540.
6. Bonnans C, Fukunaga K, Levy MA, and Levy BD: Lipoxin A4 regulates bronchial epithelial cell responses to acid injury. Am J Pathol 2006;168:1064-1072.
7. Bonville CA, Rosenberg HF, and Domachowske JB: Macrophage inflammatory protein-1alpha and RANTES are present in nasal secretions during ongoing upper respiratory tract infection. Pediatr Allergy Immunol 1999;10:39-44.
8. Brannon TS, MacRitchie AN, Jaramillo MA, Sherman TS, Yuhanna IS, Margraf LR, and Shaul PW: Ontogeny of cyclooxygenase-1 and cyclooxygenase-2 gene expression in ovine lung. Am J Physiol 1998;274:L66-L71.
9. Cutlip RC, and Lehmkuhl HD: Lesions in lambs experimentally infected with bovine respiratory syncytial virus. Am J Vet Res 1979;40:1479-1482.
10. Demoly P, Jaffuel D, Lequeux N, et al.: Prostaglandin H synthase 1 and 2 immunoreactivities in the bronchial mucosa of asthmatics. Am J Respir Crit Care Med 1997;155:670-675.
11. Ermert L, Ermert M, Goppelt-Struebe M, et al.: Cyclooxygenase isoenzyme localization and mRNA expression in rat lungs. Am J Respir Cell Mol Biol 1998;18:479-488.
12. Fukunaga K, Kohli P, Bonnans C, Fredenburgh LE, and Levy BD: Cyclooxygenase 2 plays a pivotal role in the resolution of acute lung injury. J Immunol 2005;174:5033-5039.
13. Fulkerson WJ, MacIntyre N, Stamler J, and Crapo JD: Pathogenesis and treatment of the adult respiratory distress syndrome. Arch Intern Med 1996;156:29-38.
14. Gershwin LJ, Giri SN, Stewart RS, and Chen J: Prostaglandin and thromboxane concentrations in plasma and lung lavage fluids during sequential infection of vaccinated and nonvaccinated calves with bovine respiratory syncytial virus. Am J Vet Res 1989;50:1254-1262.
15. Graham BS, Rutigliano JA, and Johnson TR: Respiratory syncytial virus immunobiology and pathogenesis. Virology 2002;297:1-7.
16. Grubor B, Gallup JM, Meyerholz DK, Crouch E, Evans RB, Brogden KA, Lehmkuhl HD, and Ackermann MR: Enhanced surfactant protein and defensin mRNA levels and reduced viral replication during paramyxoviral pneumonia in neonatal lambs. Clin Diag Lab Immunol 2004;11:599-607.
17. Hall CB: Respiratory syncytial virus and parainfluenza virus. N Engl J Med 2001;344:1917-1928.
18. Hasturk S, Kemp B, Kalapurakal SK, Kurie JM, Hong WK, and Lee JS: Expression of cyclooxygenase-1 and cyclooxygenase- 2 in bronchial epithelium and non-small cell lung carcinoma. Cancer 2002;94:1023-10231.
19. Hempel SL, Monick MM, and Hunninghake GW: Lipopolysaccharide induces prostaglandin H synthase-2 protein and mRNA in human alveolar macrophages and blood monocytes. J Clin Invest 1994;93:391-396
20. Holtzman MJ: Arachidonic acid metabolism. Implications of biological chemistry for lung function and disease. Am Rev Respir Dis 1991;143:188-203.
21. Hornsleth A, Loland L, and Larsen LB: Cytokines and chemokines in respiratory secretion and severity of disease in infants with respiratory syncytial virus (RSV) infection. Cytokines and chemokines in respiratory secretion and severity of disease in infants with respiratory syncytial virus (RSV) infection. J Clin Virol 2001;21:163-170.
22. Jackson BA, Goldstein RH, Roy R, Cozzani M, Taylor L, and Polgar P: Effects of transforming growth factor beta and interleukin-1 beta on expression of cyclooxygenase 1 and 2 and phospholipase A2 mRNA in lung fibroblasts and endothelial cells in culture. Biochem Biophys Res Commun 1993;197:1465-1474.
23. Johnson JE, Gonzales RA, Olson SJ, Wright PF, and Graham BS: The histopathology of fatal untreated human respiratory syncytial virus infection. Mod Pathol 2007;20:108-119.
24. Khan KN, Stanfield K, Trajkovic D, and Harris RK: Cyclooxygenase- 2 expression in inflammatory lung lesions of nonhuman primates. Vet Pathol 2000;37:512-516.
25. Lehmkuhl HD, and Cutlip RC: Experimental parainfluenza type 3 infection in young lambs: clinical, microbiological, and serological response. Vet Microbiol 1983; 8:437-442.
26. Liu T, Zaman W, Kaphalia BS, Ansari GA, Garofalo RP, and Casola A: RSV-induced prostaglandin E2 production occurs via cPLA2 activation: role in viral replication. Virology 2005;343:12-24.
27. Meyerholz DK, Grubor B, Fach SJ, Sacco RE, Lehmkuhl HD, Gallup JM, and Ackermann MR: Reduced clearance of respiratory syncytial virus in a preterm lamb model. Microbes Infect 2004;6:1312-1319.
28. Mitchell JA, Belvisi MG, Akarasereenont P, et al.: Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells: regulation by dexamethasone. Br J Pharmacol 1994;113:1008-1014.
29. Profita M, Sala A, Bonanno A, et al.: Increased prostaglandin E2 concentrations and cyclooxygenase-2 expression in asthmatic subjects with sputum eosinophilia. J Allergy Clin Immunol 2003;112:709-716.
30. Radi ZA: Pathophysiology of cyclooxygenease inhibition in animal models. Toxicologic Pathol 2009;37:34-46.
31. Radi ZA, and Ostroski R: Pulmonary and cardiorenal cyclooxygenase-1 (COX-1),-2 (COX-2), and microsomal prostaglandin E synthase-1 (mPGES-1) and-2 (mPGES-2) expression in a hypertension model. Mediators Inflamm 2007;2007:85091.
32. Richardson JY, Ottolini MG, Pletneva L, et al.: Respiratory syncytial virus (RSV) infection induces cyclooxygenase 2: a potential target for RSV therapy. J Immunol 2005;174:4356-4364.
33. Rolin S, Masereel B, and Dogne JM: Prostanoids as pharmacological targets in COPD and asthma. Eur J Pharmacol 2006;533:89-100.
34. Seibert K, Zhang Y, Leahy K, et al.: Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci USA 1994;91: 12013-12017.
35. Seymour ML, Gilby N, Bardin PG, et al.: Rhinovirus infection increases 5-lipoxygenase and cyclooxygenase-2 in bronchial biopsy specimens from nonatopic subjects. J Infect Dis 2002; 185:540-544.
36. Steer SA, and Corbett JA: The role and regulation of COX-2 during viral infection. Viral Immunol 2003;16:447-460.
37. Sznajer Y, Westcott JY, Wenzel SE, Mazer B, Tucci M, and Toledano BJ: Airway eicosanoids in acute severe respiratory syncytial virus bronchiolitis. J Pediatr 2004;145:115-118.
38. Tamaoki J, Chiyotani A, Kobayashi K, Sakai N, Kanemura T, and Takizawa T: Effect of indomethacin on bronchorrhea in patients with chronic bronchitis, diffuse panbronchiolitis, or bronchiectasis. Am Rev Respir Dis 1992;145:548-552.
39. Takizawa H: Airway epithelial cells as regulators of airway inflammation. Int J Mol Med 1998;1:367-378.
40. Takizawa H: Bronchial epithelial cells in allergic reactions. Curr Drug Targets Inflamm Allergy 2005;4:305-311.
41. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, and Fukuda K: Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003;289:179-186. (Pubitemid 36068705)
42. Vigano T, Toia A, Crivellari MT, Galli G, Mezzetti M, and Folco GC: Prostaglandin synthetase inhibition and formation of lipoxygenase products in immunologically challenged normal human lung parenchyma. Eicosanoids 1998;1:73-77.
43. Wallace JL: Commonality of defensive roles of COX-2 in the lung and gut. Am J Pathol 2006;168:1060-1063.
44. Watkins DN, Garlepp MJ, and Thompson PJ: Regulation of the inducible cyclo-oxygenase pathway in human cultured airway epithelial (A549) cells by nitric oxide. Br J Pharmacol 1997;121:1482-1488.
45. Wilborn J, Crofford LJ, Burdick MD, Kunkel SL, Strieter RM, and Peters-Golden M: Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2. J Clin Invest 1995;95:1861-1868.
46. Wilborn J, DeWitt DL, and Peters-Golden M: Expression and role of cyclooxygenase isoforms in alveolar and peritoneal macrophages. Am J Physiol 1995;268:L294-L301.